DOW JONES27,960.80-1031.61 -3.56%
S&P 5003,225.89-111.86 -3.35%
NASDAQ9,221.28-355.31 -3.71%

Cantor Fitzgerald Maintains Overweight on Collegium Pharmaceutical, Raises Price Target to $30

Cantor Fitzgerald analyst Brandon Folkes maintains Collegium Pharmaceutical (NASDAQ:COLL) with a Overweight and raises the price target from $24 to $30.

Benzinga · 02/07/2020 16:39

Cantor Fitzgerald analyst Brandon Folkes maintains Collegium Pharmaceutical (NASDAQ:COLL) with a Overweight and raises the price target from $24 to $30.